Softkemo Pharma Corp.
Records under this name other than the patents Softkemo Pharma Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 2 of 2 · Back to Softkemo Pharma Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,389,558 | Bendamustine amphiphilic anionic compositions Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 8,148,338 | Doxorubicin formulations for anti-cancer use Lapsed on the fee record Ended Apr 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2024 | From the USPTO record |